Cargando…
Research Progress of Myocardial Fibrosis and Atrial Fibrillation
With the aging population and the increasing incidence of basic illnesses such as hypertension and diabetes (DM), the incidence of atrial fibrillation (AF) has increased significantly. AF is the most common arrhythmia in clinical practice, which can cause heart failure (HF) and ischemic stroke (IS),...
Autores principales: | Li, Guangling, Yang, Jing, Zhang, Demei, Wang, Xiaomei, Han, Jingjing, Guo, Xueya |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9357935/ https://www.ncbi.nlm.nih.gov/pubmed/35958428 http://dx.doi.org/10.3389/fcvm.2022.889706 |
Ejemplares similares
-
Predicting Late Recurrence of Atrial Fibrillation After Radiofrequency Ablation in Patients With Atrial Fibrillation: Comparison of C2HEST and HATCH Scores
por: Han, Jingjing, et al.
Publicado: (2022) -
Blanking period antiarrhythmic drugs after catheter ablation for atrial fibrillation: a meta-analysis of randomized controlled trials
por: Chen, Gang, et al.
Publicado: (2023) -
Development and validation of a novel risk model for predicting atrial fibrillation recurrence risk among paroxysmal atrial fibrillation patients after the first catheter ablation
por: Li, Guangling, et al.
Publicado: (2022) -
Research progress of non-coding RNA in atrial fibrillation
por: Xue, Zongqian, et al.
Publicado: (2023) -
The impact of myocardial fibrosis biomarkers in a heart failure population with atrial fibrillation—The HARVEST-Malmö study
por: Nezami, Zainu, et al.
Publicado: (2022)